BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8181261)

  • 1. Randomized trial comparing nicotinamide and nicotinamide plus cyclosporin in recent onset insulin-dependent diabetes (IMDIAB 1). The IMDIAB Study Group.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabet Med; 1994; 11(1):98-104. PubMed ID: 8181261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of nicotinamide and steroid versus nicotinamide in recent-onset IDDM. The IMDIAB II Study.
    Pozzilli P; Visalli N; Boccuni ML; Baroni MG; Buzzetti R; Fioriti E; Signore A; Cavallo MG; Andreani D; Lucentini L
    Diabetes Care; 1994 Aug; 17(8):897-900. PubMed ID: 7956639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Double blind trial of nicotinamide in recent-onset IDDM (the IMDIAB III study).
    Pozzilli P; Visalli N; Signore A; Baroni MG; Buzzetti R; Cavallo MG; Boccuni ML; Fava D; Gragnoli C; Andreani D
    Diabetologia; 1995 Jul; 38(7):848-52. PubMed ID: 7556988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vitamin E and nicotinamide have similar effects in maintaining residual beta cell function in recent onset insulin-dependent diabetes (the IMDIAB IV study).
    Pozzilli P; Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Romiti A; Giovannini C; Lucentini L; Matteoli MC; Crinò A; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Suppa M; Sulli N; De Mattia G; Faldetta MR
    Eur J Endocrinol; 1997 Sep; 137(3):234-9. PubMed ID: 9330586
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized trial of nicotinamide and vitamin E in children with recent onset type 1 diabetes (IMDIAB IX).
    Crinò A; Schiaffini R; Manfrini S; Mesturino C; Visalli N; Beretta Anguissola G; Suraci C; Pitocco D; Spera S; Corbi S; Matteoli MC; Patera IP; Manca Bitti ML; Bizzarri C; Pozzilli P;
    Eur J Endocrinol; 2004 May; 150(5):719-24. PubMed ID: 15132730
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI).
    Visalli N; Cavallo MG; Signore A; Baroni MG; Buzzetti R; Fioriti E; Mesturino C; Fiori R; Lucentini L; Matteoli MC; Crinò A; Corbi S; Spera S; Teodonio C; Paci F; Amoretti R; Pisano L; Suraci C; Multari G; Sulli N; Cervoni M; De Mattia G; Faldetta MR; Boscherini B; Pozzilli P
    Diabetes Metab Res Rev; 1999; 15(3):181-5. PubMed ID: 10441040
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum angiotensin-converting enzyme levels in patients with recent-onset insulin-dependent diabetes after one year of low-dose cyclosporin therapy. IMDIAB Study Group.
    Letizia C; d'Ambrosio C; De Ciocchis A; Scavo D; Pozzilli P
    Int J Clin Pharmacol Res; 1995; 15(5-6):209-13. PubMed ID: 8835619
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural course of remission in IDDM during 1st yr after diagnosis.
    Martin S; Pawlowski B; Greulich B; Ziegler AG; Mandrup-Poulsen T; Mahon J
    Diabetes Care; 1992 Jan; 15(1):66-74. PubMed ID: 1737543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.
    Pozzilli P; Pitocco D; Visalli N; Cavallo MG; Buzzetti R; Crinò A; Spera S; Suraci C; Multari G; Cervoni M; Manca Bitti ML; Matteoli MC; Marietti G; Ferrazzoli F; Cassone Faldetta MR; Giordano C; Sbriglia M; Sarugeri E; Ghirlanda G
    Diabetologia; 2000 Aug; 43(8):1000-4. PubMed ID: 10990077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A trial of nicotinamide in newly diagnosed patients with type 1 (insulin-dependent) diabetes mellitus.
    Chase HP; Butler-Simon N; Garg S; McDuffie M; Hoops SL; O'Brien D
    Diabetologia; 1990 Jul; 33(7):444-6. PubMed ID: 2144835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of nicotinamide treatment on the residual insulin secretion in type 1 (insulin-dependent) diabetic patients.
    Vague P; Picq R; Bernal M; Lassmann-Vague V; Vialettes B
    Diabetologia; 1989 May; 32(5):316-21. PubMed ID: 2526769
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BCG vaccine in insulin-dependent diabetes mellitus. IMDIAB Group.
    Pozzilli P
    Lancet; 1997 May; 349(9064):1520-1. PubMed ID: 9167468
    [No Abstract]   [Full Text] [Related]  

  • 13. Nicotinamide increases C-peptide secretion in patients with recent onset type 1 diabetes.
    Pozzilli P; Visalli N; Ghirlanda G; Manna R; Andreani D
    Diabet Med; 1989; 6(7):568-72. PubMed ID: 2527694
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adjuvant therapy in recent onset type 1 diabetes at diagnosis and insulin requirement after 2 years.
    Pozzilli P; Visalli N; Buzzetti R; Baroni MG; Boccuni ML; Fioriti E; Signore A; Mesturino C; Valente L; Cavallo MG
    Diabete Metab; 1995 Feb; 21(1):47-9. PubMed ID: 7781843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A preliminary multicentre study of the treatment of recently diagnosed type 1 diabetes by combination nicotinamide-cyclosporin therapy.
    Vialettes B; Picq R; du Rostu M; Charbonnel B; Rodier M; Mirouze J; Vexiau P; Passa P; Pehuet M; Elgrably F
    Diabet Med; 1990; 7(8):731-5. PubMed ID: 2147636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypersensitivity to insulin during remissions in cyclosporin-treated IDDM patients.
    Burcelin RG; Eddouks M; Beylot M; Normand S; Boitard C; Feutren G; Landais P; Riou JP; Girard JR; Bach JF
    Diabetes Care; 1993 Jun; 16(6):881-8. PubMed ID: 8325202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus.
    Crinó A; Schiaffini R; Ciampalini P; Suraci MC; Manfrini S; Visalli N; Matteoli MC; Patera P; Buzzetti R; Guglielmi C; Spera S; Costanza F; Fioriti E; Pitocco D; Pozzilli P;
    J Pediatr Endocrinol Metab; 2005 Aug; 18(8):749-54. PubMed ID: 16200840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term results of early cyclosporin therapy in juvenile IDDM.
    De Filippo G; Carel JC; Boitard C; Bougnères PF
    Diabetes; 1996 Jan; 45(1):101-4. PubMed ID: 8522052
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early administration of an immunomodulator and induction of remission in insulin-dependent diabetes mellitus.
    Giordano C; Pantŏ F; Amato MP; Sapienza N; Pugliese A; Galluzzo A
    J Autoimmun; 1990 Oct; 3(5):611-7. PubMed ID: 2252529
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group.
    Diabetes; 1988 Nov; 37(11):1574-82. PubMed ID: 2903105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.